Philipp Gut

EPFL Innovation Park
Lausanne, VD 1015, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Dose-intensified SBRT for vertebral oligometastases: results from a prospective clinical trial.

Dose-intensified SBRT for vertebral oligometastases: results from a prospective clinical trial.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: January 30, 2025

NAD+ and Sirt5 restore mitochondrial bioenergetics failure and improve locomotor defects caused by sucla2 mutations.

NAD+ and Sirt5 restore mitochondrial bioenergetics failure and improve locomotor defects caused by sucla2 mutations.

Journal: JCI insight

Published: April 05, 2024

Dose-intensified stereotactic body radiotherapy for painful vertebral metastases: A randomized phase 3 trial.

Dose-intensified stereotactic body radiotherapy for painful vertebral metastases: A randomized phase 3 trial.

Journal: Cancer

Published: December 20, 2023

A biological age based on common clinical markers predicts health trajectory and mortality risk in dogs.

A biological age based on common clinical markers predicts health trajectory and mortality risk in dogs.

Journal: GeroScience

Published: November 14, 2023

Herbal terpenoids activate autophagy and mitophagy through modulation of bioenergetics and protect from metabolic stress, sarcopenia and epigenetic aging.

Herbal terpenoids activate autophagy and mitophagy through modulation of bioenergetics and protect from metabolic stress, sarcopenia and epigenetic aging.

Journal: Nature aging

Published: August 14, 2023

A meta-analysis comparing the effectiveness of alternate day fasting, the 5:2 diet, and time-restricted eating for weight loss.

A meta-analysis comparing the effectiveness of alternate day fasting, the 5:2 diet, and time-restricted eating for weight loss.

Journal: Obesity (Silver Spring, Md.)

Published: March 16, 2022

Validation of the Decipher genomic classifier in patients receiving salvage radiotherapy without hormone therapy after radical prostatectomy - an ancillary study of the SAKK 09/10 randomized clinical trial.

Validation of the Decipher genomic classifier in patients receiving salvage radiotherapy without hormone therapy after radical prostatectomy - an ancillary study of the SAKK 09/10 randomized clinical trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: February 07, 2022

A Randomized Controlled Clinical Trial in Healthy Older Adults to Determine Efficacy of Glycine and N-Acetylcysteine Supplementation on Glutathione Redox Status and Oxidative Damage.

A Randomized Controlled Clinical Trial in Healthy Older Adults to Determine Efficacy of Glycine and N-Acetylcysteine Supplementation on Glutathione Redox Status and Oxidative Damage.

Journal: Frontiers in aging

Published: January 11, 2022

Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial.

Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial.

Journal: European urology

Published: December 23, 2020

Lack of consensus on an aging biology paradigm? A global survey reveals an agreement to disagree, and the need for an interdisciplinary framework.

Lack of consensus on an aging biology paradigm? A global survey reveals an agreement to disagree, and the need for an interdisciplinary framework.

Journal: Mechanisms of ageing and development

Published: May 27, 2020

MondoA regulates gene expression in cholesterol biosynthesis-associated pathways required for zebrafish epiboly.

MondoA regulates gene expression in cholesterol biosynthesis-associated pathways required for zebrafish epiboly.

Journal: eLife

Published: March 19, 2020

SUCLA2 mutations cause global protein succinylation contributing to the pathomechanism of a hereditary mitochondrial disease.

SUCLA2 mutations cause global protein succinylation contributing to the pathomechanism of a hereditary mitochondrial disease.

Journal: Nature communications

Published: February 25, 2020

Showing 1-12 of 38

Last Updated: 09/26/2026